Detailed Explanation
Feasibility assessment represents the critical first step in clinical trial planning, enabling sponsors to make informed decisions about site selection, enrollment projections, and resource allocation. This comprehensive evaluation examines multiple dimensions of trial viability, including the availability of suitable patient populations, investigator expertise and interest, site infrastructure and experience, competitive trial landscape, and regulatory considerations specific to each country or region under consideration.